newsfilter
← Latest News
PR Newswire·

Emmaus Life Sciences to Present at Investor Conferences in May

TORRANCE, Calif., April 26, 2022 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX:EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced participation in the following investor confe